Free Trial

Neuberger Berman Group LLC Buys 82,220 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background
Remove Ads

Neuberger Berman Group LLC grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 19.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 498,674 shares of the semiconductor company's stock after purchasing an additional 82,220 shares during the quarter. Neuberger Berman Group LLC owned about 0.32% of Synopsys worth $242,036,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Caprock Group LLC grew its stake in shares of Synopsys by 0.5% during the fourth quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company's stock worth $1,803,000 after buying an additional 20 shares during the last quarter. Compagnie Lombard Odier SCmA grew its stake in shares of Synopsys by 1.1% during the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company's stock valued at $898,000 after buying an additional 20 shares during the last quarter. Edge Capital Group LLC lifted its holdings in Synopsys by 1.2% in the fourth quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company's stock worth $791,000 after buying an additional 20 shares during the period. Barden Capital Management Inc. increased its holdings in shares of Synopsys by 1.1% during the fourth quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock valued at $889,000 after acquiring an additional 20 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. lifted its holdings in Synopsys by 28.6% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after acquiring an additional 20 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on SNPS shares. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 target price on shares of Synopsys in a research report on Tuesday, February 25th. Mizuho dropped their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research note on Tuesday. Wells Fargo & Company cut their target price on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC reaffirmed a "buy" rating and issued a $650.00 price target on shares of Synopsys in a report on Thursday, February 27th. Finally, Redburn Atlantic assumed coverage on shares of Synopsys in a research note on Monday, January 13th. They set a "buy" rating and a $600.00 price target on the stock. One investment analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of "Moderate Buy" and an average target price of $623.17.

View Our Latest Research Report on SNPS

Synopsys Stock Up 0.6 %

Shares of SNPS traded up $2.56 during midday trading on Tuesday, hitting $424.54. The company had a trading volume of 341,159 shares, compared to its average volume of 1,088,574. The stock has a market cap of $65.64 billion, a price-to-earnings ratio of 29.24, a PEG ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80. The company's 50 day moving average price is $455.38 and its 200 day moving average price is $497.37.

Insider Buying and Selling at Synopsys

In related news, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the sale, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. The trade was a 93.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Geus Aart De sold 15,705 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares of the company's stock, valued at $51,850,925.82. This represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 47,909 shares of company stock worth $22,794,835 over the last ninety days. Company insiders own 0.62% of the company's stock.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Today: Your Guide to Smarter Options Trades Cover

Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY Now as Tariff Uncertainty Fades

5 Stocks to BUY Now as Tariff Uncertainty Fades

These 5 Stocks have been beaten down by tariffs, but now that the uncertainty is fading, they're set for a rebound with all the potential downside already priced in.

Related Videos

7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads